Celgene Alpine Investment Co., LLC 4/A
4/A · AGIOS PHARMACEUTICALS INC · Filed Jan 31, 2018
Insider Transaction Report
Form 4/AAmended
CELGENE CORP /DE/
10% Owner
Transactions
- Purchase
Common Stock
2018-01-23$67.00/sh+851,154$57,027,318→ 1,374,599 total
Holdings
- 5,343,834(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]This Form 4 Amendment is being submitted to correct the date of earliest transaction in box 3 to reflect January 23, 2018.
- [F2]Of these shares, 624,575 shares are owned directly by Celgene Switzerland LLC, 708,333 shares are owned directly by Celgene Alpine Investment Co. LLC, and 4,010,926 shares are owned directly by Celgene European Investment Company LLC, each a wholly-owned subsidiary of Celgene Corporation ("Celgene"), and Celgene has the power to vote, acquire, hold and dispose of all such shares. Celgene disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.